Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035548 | SCV000059198 | likely benign | not specified | 2007-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000863844 | SCV001004566 | likely benign | Hypertrophic cardiomyopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001180863 | SCV001345904 | likely benign | Cardiomyopathy | 2019-03-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000035548 | SCV001437401 | likely benign | not specified | 2020-09-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711365 | SCV001940799 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002433493 | SCV002748845 | likely benign | Cardiovascular phenotype | 2019-05-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000863844 | SCV004836677 | likely benign | Hypertrophic cardiomyopathy | 2024-01-11 | criteria provided, single submitter | clinical testing |